October Pharma S.A.E (EGX:OCPH)
102.49
0.00 (0.00%)
At close: May 13, 2025
October Pharma S.A.E Balance Sheet
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 52.52 | 45.3 | 6.92 | 16.72 | 1.86 | Upgrade
|
Cash & Short-Term Investments | 52.52 | 45.3 | 6.92 | 16.72 | 1.86 | Upgrade
|
Cash Growth | 15.96% | 554.89% | -58.64% | 798.79% | -89.19% | Upgrade
|
Accounts Receivable | 269.1 | 209.3 | 144.45 | 97.04 | 84.73 | Upgrade
|
Other Receivables | - | 0.24 | 0.27 | 0.41 | 0.34 | Upgrade
|
Receivables | 642.02 | 579.83 | 364.81 | 118.84 | 214.67 | Upgrade
|
Inventory | 320.67 | 167.62 | 252.86 | 167.84 | 140.73 | Upgrade
|
Prepaid Expenses | - | 4.52 | 1.59 | 0.89 | 0.64 | Upgrade
|
Other Current Assets | 40.83 | 33.24 | 29.45 | 26.56 | 27.68 | Upgrade
|
Total Current Assets | 1,056 | 830.51 | 655.63 | 330.86 | 385.59 | Upgrade
|
Property, Plant & Equipment | 249.49 | 216.84 | 196.27 | 115.76 | 107.8 | Upgrade
|
Other Intangible Assets | 81.01 | 90.74 | 98.18 | 105.4 | 112.76 | Upgrade
|
Long-Term Deferred Tax Assets | 27.3 | - | - | - | - | Upgrade
|
Other Long-Term Assets | - | - | - | 1.03 | - | Upgrade
|
Total Assets | 1,414 | 1,138 | 950.08 | 553.06 | 606.15 | Upgrade
|
Accounts Payable | 168.62 | 82.27 | 92.51 | 35.37 | 26.22 | Upgrade
|
Accrued Expenses | - | 16.95 | 22.99 | 23.76 | 26 | Upgrade
|
Short-Term Debt | 427.28 | 216.99 | 203.34 | 15.25 | 165.64 | Upgrade
|
Current Portion of Long-Term Debt | 37.99 | 38.15 | 41.36 | 18.16 | 24.38 | Upgrade
|
Current Portion of Leases | - | 0.26 | 0.42 | 0.37 | - | Upgrade
|
Current Income Taxes Payable | 57.43 | 61.55 | 41.29 | 37.37 | 22.7 | Upgrade
|
Other Current Liabilities | 40.84 | 40.99 | 22.66 | 21.91 | 15.48 | Upgrade
|
Total Current Liabilities | 732.16 | 457.17 | 424.56 | 152.19 | 280.43 | Upgrade
|
Long-Term Debt | 57.76 | 68.57 | 77.42 | 39.69 | 58.3 | Upgrade
|
Long-Term Leases | - | - | 0.26 | 0.68 | - | Upgrade
|
Long-Term Deferred Tax Liabilities | - | 12.78 | 11.78 | 10.33 | 2.85 | Upgrade
|
Total Liabilities | 844.49 | 548.55 | 524.55 | 213.6 | 352.29 | Upgrade
|
Common Stock | 120 | 120 | 120 | 60 | 60 | Upgrade
|
Retained Earnings | 449.35 | 469.54 | 305.52 | 279.46 | 193.86 | Upgrade
|
Shareholders' Equity | 569.35 | 589.54 | 425.52 | 339.46 | 253.86 | Upgrade
|
Total Liabilities & Equity | 1,414 | 1,138 | 950.08 | 553.06 | 606.15 | Upgrade
|
Total Debt | 523.03 | 323.98 | 322.79 | 74.15 | 248.32 | Upgrade
|
Net Cash (Debt) | -470.5 | -278.68 | -315.87 | -57.43 | -246.46 | Upgrade
|
Net Cash Per Share | -33.90 | -23.22 | -26.32 | -4.79 | -20.54 | Upgrade
|
Filing Date Shares Outstanding | 19.52 | 12 | 12 | 12 | 12 | Upgrade
|
Total Common Shares Outstanding | 19.52 | 12 | 12 | 12 | 12 | Upgrade
|
Working Capital | 323.88 | 373.34 | 231.07 | 178.67 | 105.16 | Upgrade
|
Book Value Per Share | 29.17 | 49.13 | 35.46 | 28.29 | 21.16 | Upgrade
|
Tangible Book Value | 488.34 | 498.79 | 327.34 | 234.05 | 141.1 | Upgrade
|
Tangible Book Value Per Share | 25.02 | 41.57 | 27.28 | 19.50 | 11.76 | Upgrade
|
Land | - | 0.42 | 0.42 | 0.42 | 0.42 | Upgrade
|
Buildings | - | 36.19 | 36.12 | 35.78 | 35.72 | Upgrade
|
Machinery | - | 145.86 | 148.8 | 141.84 | 136.56 | Upgrade
|
Construction In Progress | - | 129.44 | 100.41 | 19 | 6.57 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.